Public Profile

Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc., a pioneering company in the field of sleep-disordered breathing, is headquartered in the United States. Founded in 2016, Vivos has rapidly established itself as a leader in the dental and medical industries, focusing on innovative solutions for obstructive sleep apnoea (OSA) and related conditions. The company’s flagship product, the Vivos System, offers a unique, non-invasive approach to treating OSA by addressing the underlying anatomical issues rather than merely alleviating symptoms. This distinctive methodology sets Vivos apart in a competitive market, contributing to its growing reputation and market position. With a commitment to improving patient outcomes, Vivos Therapeutics continues to expand its operational reach, making significant strides in the realm of sleep health.

DitchCarbon Score

How does Vivos Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

5

Industry Benchmark

Vivos Therapeutics, Inc.'s score of 18 is lower than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.

38%

Vivos Therapeutics, Inc.'s reported carbon emissions

Vivos Therapeutics, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is challenging to assess their carbon footprint or climate commitments in detail. However, the absence of data does not preclude the company from engaging in sustainability initiatives or aligning with industry standards for climate action. As the company progresses, it may establish measurable targets and report on its emissions, contributing to broader efforts in reducing greenhouse gas emissions within the healthcare sector.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Vivos Therapeutics, Inc.'s primary industry is Medical, precision and optical instruments, watches and clocks (33), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Vivos Therapeutics, Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Vivos Therapeutics, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

James R. Glidewell, Dental Ceramics, Inc.

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 7 days ago

Tap & Co

US
Updated 4 days ago

Herbst Gmbh

DE
Updated 4 days ago

SomnoMed Limited

AU
Health and social work services (85)
Updated 7 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers